Clinical Study of Efficacy and Safety of Raphamin in the Treatment of ARVI in Children 12-18 Years Old
Clinical trial NCT04918771 · COMPLETED
Trial details
- NCT number
- NCT04918771
- Sponsor
- Materia Medica Holding
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-29
- Primary completion
- 2023-07-21
- Enrollment
- 435
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.